Australia's Sigma Healthcare rises after Jefferies upgrades to 'buy' on growth prospects

Sigma Healthcare

20/03/2026 24:12

Updates

** Shares of Australia's pharmaceutical wholesaler Sigma Healthcare SIG.AX rise as much as 3.4% to A$2.750, logging their best day since March 6

 ** Stock hits highest level since March 11

** Analysts at Jefferies upgrade Sigma to "buy" from "hold"; PT unchanged at A$3.05

** Brokerage expects margin expansion for SIG in FY26 due to volume growth on fixed-cost base, improvements in company's wholesaling and growth in higher-margin generics

** Higher sales volumes of tirzepatide and Wegovy in H1FY26 to partially continue into H2FY26 — Jefferies

** 10 out of 13 analysts rate the stock "buy" or higher, 3 "hold" — data compiled by LSEG

** Shares down 6.5% YTD, up 4.2% for the week

(Reporting by Keshav Singh Chundawat & Rajasik Mukherjee in Bengaluru)

((Keshav.singhchundawat@thomsonreuters.com))